KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) FCF Margin (2016 - 2025)

Quest Diagnostics (DGX) has disclosed FCF Margin for 17 consecutive years, with 10.94% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 207.0% to 10.94% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 12.32% through Dec 2025, up 311.0% year-over-year, with the annual reading at 12.32% for FY2025, 311.0% up from the prior year.
  • FCF Margin hit 10.94% in Q4 2025 for Quest Diagnostics, down from 14.88% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 23.71% in Q1 2021 to a low of 1.42% in Q1 2023.
  • Historically, FCF Margin has averaged 12.17% across 5 years, with a median of 13.15% in 2024.
  • Biggest five-year swings in FCF Margin: skyrocketed 1471bps in 2021 and later plummeted -1739bps in 2023.
  • Year by year, FCF Margin stood at 12.28% in 2021, then tumbled by -35bps to 8.02% in 2022, then skyrocketed by 148bps to 19.89% in 2023, then plummeted by -35bps to 13.01% in 2024, then decreased by -16bps to 10.94% in 2025.
  • Business Quant data shows FCF Margin for DGX at 10.94% in Q4 2025, 14.88% in Q3 2025, and 15.79% in Q2 2025.